BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 12509223)

  • 21. Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR.
    Park JE; Chen HH; Winer J; Houck KA; Ferrara N
    J Biol Chem; 1994 Oct; 269(41):25646-54. PubMed ID: 7929268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin II regulation of vascular endothelial growth factor and receptors Flt-1 and KDR/Flk-1 in cyclosporine nephrotoxicity.
    Shihab FS; Bennett WM; Isaac J; Yi H; Andoh TF
    Kidney Int; 2002 Aug; 62(2):422-33. PubMed ID: 12110003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor.
    Lu D; Jimenez X; Zhang H; Wu Y; Bohlen P; Witte L; Zhu Z
    Cancer Res; 2001 Oct; 61(19):7002-8. PubMed ID: 11585724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF.
    Seetharam L; Gotoh N; Maru Y; Neufeld G; Yamaguchi S; Shibuya M
    Oncogene; 1995 Jan; 10(1):135-47. PubMed ID: 7824266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-gamma and migration of endothelial cells expressing Flt 1.
    Landgren E; Schiller P; Cao Y; Claesson-Welsh L
    Oncogene; 1998 Jan; 16(3):359-67. PubMed ID: 9467961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of VEGF and its receptors Flt-1 and Flk-1/KDR is altered in lambs with increased pulmonary blood flow and pulmonary hypertension.
    Mata-Greenwood E; Meyrick B; Soifer SJ; Fineman JR; Black SM
    Am J Physiol Lung Cell Mol Physiol; 2003 Jul; 285(1):L222-31. PubMed ID: 12665467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular endothelial growth factor-dependent down-regulation of Flk-1/KDR involves Cbl-mediated ubiquitination. Consequences on nitric oxide production from endothelial cells.
    Duval M; Bédard-Goulet S; Delisle C; Gratton JP
    J Biol Chem; 2003 May; 278(22):20091-7. PubMed ID: 12649282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Src mediates stimulation by vascular endothelial growth factor of the phosphorylation of focal adhesion kinase at tyrosine 861, and migration and anti-apoptosis in endothelial cells.
    Abu-Ghazaleh R; Kabir J; Jia H; Lobo M; Zachary I
    Biochem J; 2001 Nov; 360(Pt 1):255-64. PubMed ID: 11696015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of vascular endothelial growth factor and its receptors KDR and Flt-1 in gastric cancer cells.
    Zhang H; Wu J; Meng L; Shou CC
    World J Gastroenterol; 2002 Dec; 8(6):994-8. PubMed ID: 12439912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upregulation of the angiogenic factors PlGF, VEGF and their receptors (Flt-1, Flk-1/KDR) by TSH in cultured thyrocytes and in the thyroid gland of thiouracil-fed rats suggest a TSH-dependent paracrine mechanism for goiter hypervascularization.
    Viglietto G; Romano A; Manzo G; Chiappetta G; Paoletti I; Califano D; Galati MG; Mauriello V; Bruni P; Lago CT; Fusco A; Persico MG
    Oncogene; 1997 Nov; 15(22):2687-98. PubMed ID: 9400995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased vascular endothelial growth factor 165 binding to kinase insert domain-containing receptor after infection of human endothelial cells by recombinant adenovirus encoding the Vegf(165) gene.
    Weisz A; Koren B; Cohen T; Neufeld G; Kleinberger T; Lewis BS; Flugelman MY
    Circulation; 2001 Apr; 103(14):1887-92. PubMed ID: 11294808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular endothelial cell growth factor-driven endothelial tube formation is mediated by vascular endothelial cell growth factor receptor-2, a kinase insert domain-containing receptor.
    Yang S; Xin X; Zlot C; Ingle G; Fuh G; Li B; Moffat B; de Vos AM; Gerritsen ME
    Arterioscler Thromb Vasc Biol; 2001 Dec; 21(12):1934-40. PubMed ID: 11742867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclic changes in expression of mRNA of vascular endothelial growth factor, its receptors Flt-1 and KDR/Flk-1, and Ets-1 in human corpora lutea.
    Endo T; Kitajima Y; Nishikawa A; Manase K; Shibuya M; Kudo R
    Fertil Steril; 2001 Oct; 76(4):762-8. PubMed ID: 11591411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transactivation of KDR/Flk-1 by the B2 receptor induces tube formation in human coronary endothelial cells.
    Miura S; Matsuo Y; Saku K
    Hypertension; 2003 May; 41(5):1118-23. PubMed ID: 12654712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Flt-1)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis.
    Valter MM; Hügel A; Huang HJ; Cavenee WK; Wiestler OD; Pietsch T; Wernert N
    Cancer Res; 1999 Nov; 59(21):5608-14. PubMed ID: 10554042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular permeability factor/vascular endothelial growth factor-mediated signaling in mouse mesentery vascular endothelium.
    Mukhopadhyay D; Nagy JA; Manseau EJ; Dvorak HF
    Cancer Res; 1998 Mar; 58(6):1278-84. PubMed ID: 9515816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective inhibition of vascular endothelial growth factor receptor-2 (VEGFR-2) identifies a central role for VEGFR-2 in human aortic endothelial cell responses to VEGF.
    Endo A; Fukuhara S; Masuda M; Ohmori T; Mochizuki N
    J Recept Signal Transduct Res; 2003; 23(2-3):239-54. PubMed ID: 14626450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new communication system between hepatocytes and sinusoidal endothelial cells in liver through vascular endothelial growth factor and Flt tyrosine kinase receptor family (Flt-1 and KDR/Flk-1).
    Yamane A; Seetharam L; Yamaguchi S; Gotoh N; Takahashi T; Neufeld G; Shibuya M
    Oncogene; 1994 Sep; 9(9):2683-90. PubMed ID: 8058332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Co-expression of vascular endothelial growth factor (VEGF) and its receptors (flk-1 and flt-1) in hormone-induced mammary cancer in the Noble rat.
    Xie B; Tam NN; Tsao SW; Wong YC
    Br J Cancer; 1999 Dec; 81(8):1335-43. PubMed ID: 10604730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1.
    Kim YM; Hwang S; Kim YM; Pyun BJ; Kim TY; Lee ST; Gho YS; Kwon YG
    J Biol Chem; 2002 Aug; 277(31):27872-9. PubMed ID: 12029087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.